Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children. 2013

Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
Rocky Mountain Poison and Drug Center, Denver Health and Hospital Authority, Denver, CO; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO. Electronic address: eric.lavonas@rmpdc.org.

OBJECTIVE To characterize the rates, root causes, and clinical effects of unintentional exposures to buprenorphine sublingual formulations among young children and to determine whether exposure characteristics differ between formulations. METHODS Unintentional exposures to buprenorphine-containing products among children 28 days to less than 6 years old were collected from the Researched Abuse, Diversion, and Addiction-Related Surveillance System Poison Center Program and Reckitt Benckiser Pharmaceuticals' pharmacovigilance system from October 2009-March 2012. After adjustment for drug availability, negative binomial regression was used to estimate average exposure rates. Root cause assessment was conducted, and an expert clinician panel adjudicated causality and severity of moderate to severe adverse events (AEs). RESULTS A total of 2380 cases were reviewed, including 4 deaths. Exposures to buprenorphine-naloxone combination film were significantly less frequent than exposures to buprenorphine tablets (rate ratio 3.5 [95% CI, 2.7-4.5]) and buprenorphine-naloxone combination tablets (rate ratio 8.8 [7.2-10.6]). The most commonly identified root causes were medication stored in sight, accessed from a bag or purse, and not stored in the original packaging. Among 536 panel review cases, the most common AEs reported for all formulations were lethargy, respiratory depression, miosis, and vomiting. The highest level AE severity did not differ significantly by formulation. CONCLUSIONS Unintentional exposure to buprenorphine can cause central nervous system depression, respiratory depression, and death in young children. Exposure rates to film formulations are significantly less than to tablet formulations. Package and storage deficiencies contribute to unintentional exposures in young children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D011039 Poison Control Centers Facilities which provide information concerning poisons and treatment of poisoning in emergencies. Centers, Poison Control,Center, Poison Control,Control Centers, Poison,Poison Control Center
D012042 Registries The systems and processes involved in the establishment, support, management, and operation of registers, e.g., disease registers. Parish Registers,Population Register,Parish Register,Population Registers,Register, Parish,Register, Population,Registers, Parish,Registers, Population,Registry
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D002047 Buprenorphine A derivative of the opioid alkaloid THEBAINE that is a more potent and longer lasting analgesic than MORPHINE. It appears to act as a partial agonist at mu and kappa opioid receptors and as an antagonist at delta receptors. The lack of delta-agonist activity has been suggested to account for the observation that buprenorphine tolerance may not develop with chronic use. 6029-M,Buprenex,Buprenorphine Hydrochloride,Buprex,Prefin,RX-6029-M,Subutex,Temgesic,Temgésic,6029 M,6029M,Hydrochloride, Buprenorphine,RX 6029 M,RX6029M
D002490 Central Nervous System The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges. Cerebrospinal Axis,Axi, Cerebrospinal,Axis, Cerebrospinal,Central Nervous Systems,Cerebrospinal Axi,Nervous System, Central,Nervous Systems, Central,Systems, Central Nervous
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004349 Drug Packaging Containers, packaging, and packaging materials for drugs and BIOLOGICAL PRODUCTS. These include those in ampule, capsule, tablet, solution or other forms. Packaging includes immediate-containers, secondary-containers, and cartons. In the United States, such packaging is controlled under the Federal Food, Drug, and Cosmetic Act which also stipulates requirements for tamper-resistance and child-resistance. Similar laws govern use elsewhere. (From Code of Federal Regulations, 21 CFR 1 Section 210, 1993) DRUG LABELING is also available. Drug Containers and Closures,Packaging, Drug,Drug Containers,Container, Drug,Containers, Drug,Drug Container,Drug Packagings,Packagings, Drug

Related Publications

Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
January 2017, Journal of the American Pharmacists Association : JAPhA,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
January 2017, Clinical toxicology (Philadelphia, Pa.),
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
June 2018, Pediatrics,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
October 2006, Pediatrics,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
February 2006, The Annals of pharmacotherapy,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
January 2006, MMWR. Morbidity and mortality weekly report,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
February 2020, Drug safety,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
August 2018, The Journal of emergency medicine,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
June 2017, The Journal of emergency medicine,
Eric J Lavonas, and William Banner, and Pamela Bradt, and Becki Bucher-Bartelson, and Kimberly R Brown, and Pradeep Rajan, and Lenn Murrelle, and Richard C Dart, and Jody L Green
February 2001, Paediatrics & child health,
Copied contents to your clipboard!